Zaidi

Zaidi v. Adamas Pharmaceuticals, Inc.

Good Law
United States District Court, Northern District of CaliforniaMarch 29, 20234:19-cv-08051California214 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 ALI ZAIDI, et al., Case No. 19-cv-08051-JSW Plaintiffs,

ORDER DISMISSING SECTION 20(A)

V. CLAIM ADAMAS PHARMACEUTICALS, INC., et al., Defendants.

E In the parties’ joint case management conference statement, Defendant Richard King 14 || raised an issue of whether he can be held liable under Section 20(a). The Court has reviewed its || Order granting, in part, and denying, in part, Defendants’ motion to dismiss. In order to state a || claim under Section 20(a), a plaintiff must prove “(1) a primary violation of federal securities laws i ...5 and (2) that the defendant exercised actual power or control over the primary violator.” Z || Howard v. Everex Systs., Inc., 228 F.3d 1057, 1065 (9th Cir. 2000) (emphasis added). Based on || the Court’s ruling, King is the only defendant alleged to have committed a primary violation of || Section 10(b). The Court should have, and now does, dismiss…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.